Clinical utility of anti-cyclic citrullinated peptide antibodies assay in patients with rheumatoid arthritis

Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/10595

DC Field	Value	Language
dc.contributor.author	N. Marina	en_US
dc.contributor.author	D. Spasovski	en_US
dc.contributor.author	L. Damjanovska	en_US
dc.contributor.author	S.M. Percinkova	en_US
dc.contributor.author	T. Gruev	en_US
dc.contributor.author	J. Calovski	en_US
dc.date.accessioned	2021-03-02T10:44:55Z	-
dc.date.available	2021-03-02T10:44:55Z	-
dc.date.issued	2009	-
dc.identifier.uri	http://hdl.handle.net/20.500.12188/10595	-
dc.language.iso	en	en_US
dc.relation.ispartof	Annals of the Rheumatic Diseases	en_US
dc.title	Clinical utility of anti-cyclic citrullinated peptide antibodies assay in patients with rheumatoid arthritis	en_US
dc.type	Proceeding article	en_US
dc.relation.conference	ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY; EULAR 2009	en_US
dc.identifier.volume	68	-
dc.identifier.issue	Suppl 3	-
item.fulltext	With Fulltext	-
item.grantfulltext	open	-
crisitem.author.dept	Faculty of Medicine	-
crisitem.author.dept	Faculty of Medicine	-
Appears in Collections:	Faculty of Medicine: Conference papers